Needham & Company Starts Selecta Biosciences (SELB) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St set for lower open as bond yields climb; Walmart falls
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
UBS Starts Selecta Biosciences (SELB) at Buy
July 18, 2016 9:01 AM EDTUBS initiated coverage on Selecta Biosciences (NASDAQ: SELB) with a Buy rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Selecta Biosciences click here. For more ratings news on Selecta Biosciences click here.
Shares of Selecta Biosciences closed at $14.00 yesterday.
... MoreStifel Starts Selecta Biosciences (SELB) at Buy
July 18, 2016 6:19 AM EDTStifel initiates coverage on recent IPO Selecta Biosciences (NASDAQ: SELB) with a Buy rating and a price target of $23.00.
Analyst Thomas Shrader commented, "With our increasing understanding of the molecular control of cellular function comes the increasing opportunity to correct disease states. However, many exciting... More
